Research Article
The Use of a Scoring System to Guide Thromboprophylaxis in a High-Risk Pregnant Population
Table 5
Results of thrombophilia screening in women receiving dalteparin during or after pregnancy.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| VTE: venous thromboemboloism; COCP: combined oral contraceptive pill; APA: antiphospholipid antibodies; AT: antithrombin deficiency (untyped); PC: Protein C deficiency; PS: Protein S deficiency; FVL: heterozygous Factor V Leiden; PT: heterozygous prothrombin gene G20210A mutation. All patients were screened after introduction of the scoring system. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||